Scaffold
In biomedicine, a scaffold is a structural framework that organizes biological or chemical components for a defined therapeutic purpose.
In biomedicine, a scaffold is a structural framework that organizes biological or chemical components for a defined therapeutic purpose. In regenerative medicine, scaffolds can provide a physical environment for tissue repair while supporting controlled delivery of bioactive agents. Recent examples include piezoelectric nanofiber scaffolds designed for mechanically triggered and temporally controlled delivery of bone-targeted exosome mimetics carrying Ago/AntagomiR-126, as well as mechanically optimized hybrid scaffold–stem cell constructs incorporating tendon-derived stem cells, mesenchymal stem cells, growth-factor release, and progressive mechanical stimulation for tendon regeneration. Hydrogels and related biomaterial designs are likewise investigated to coordinate cell interactions, mechanical integrity, and therapeutic delivery.
In medicinal chemistry, the term refers to the core molecular framework that is modified to generate compounds with desired affinity, potency, selectivity, stability, absorption, and safety profiles. Scaffold-based design has been applied to diverse targets and diseases, including pyrimidine frameworks for SARS-CoV-2 Mpro inhibitors, LpxC inhibitor development for multidrug-resistant Escherichia coli and other Gram-negative infections, sigma-1 receptor antagonists for antihyperalgesic activity, and carbamate, dihydropyridine–pyrazole, baicalein–isoxazole, and fluoroquinolone-derived frameworks. Such programs commonly use synthesis, screening, inhibition and cytotoxicity testing, molecular docking, molecular dynamics, in silico analyses, and related validation approaches to optimize a scaffold into a lead or therapeutic inhibitor.
Where the papers sit
11 papers from the last 6 months study scaffold directly · updated from PubMed 15 Nov 2026
Study type 0 clinical trials · 11 preclinical
Themes one subject · 1 paradigm shift
Those 11 are all about one subject.
-
Biomaterials and Drug Discovery
Biomaterials engineering and medicinal chemistry dominate this group, spanning tissue-regenerative constructs, bioinks and nanofiber delivery systems alongside small-molecule discovery. The therapeutic targets range from SARS-CoV-2 Mpro and multidrug-resistant bacteria to cholinesterases, sigma-1 receptors and GLUT4. The work emphasizes scaffold or chemical optimization, but shares no disease focus, mechanism or common translational direction. It is best viewed as a broad collection of biomedical design studies rather than a unified research program.
Scaffolds shift from passive structural or delivery platforms to mechanically responsive, temporally coordinating systems
The bone-regeneration study using piezoelectric nanofiber scaffolds and stage-specific exosome mimetics, and the rat Achilles-tendon study using hybrid scaffolds with stem cells, growth-factor release, and mechanical preconditioning, both reject the assumption that a scaffold can function mainly as a passive support or release matrix. Instead, they make scaffold activity responsive to the changing mechanical and biological demands of repair: the bone system couples loading to phase-specific miRNA delivery, while the tendon system integrates aligned architecture, sustained TGF-β3 release, stem cells, and progressive mechanical stimulation. The resulting change is to treat the scaffold as an active regulator that coordinates therapeutic timing and mechanical cues with tissue-healing stages, rather than merely carrying cells, factors, or drugs 42975284Nov 42804447Sep.
Papers
The 11 papers from the last 6 months that study scaffold directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Biomaterials and Drug Discovery (11)
- Polymeric Hydrogel-Based Multicomponent Inks Incorporated with Lanthanide-Doped Nanoconjugates for Extrusion 3D Printing. Biomacromolecules · 9 Nov 2026 PMID 43002061
- Divide and Conquer Strategy Using Piezoelectric Nanofiber Scaffolds for Stage-Specific Delivery of Bone-Targeted Exosome Mimetics with Ago/AntagomiR-126. ACS nano · 3 Nov 2026 PMID 42975284
- Granular hydrogel bioink for macroporous pancreatic spheroid scaffolds. Biofabrication · 19 Oct 2026 PMID 42896566
- Development of mechanically optimized biomimetic hybrid scaffold-stem cell constructs for functional tendon regeneration and restoration of mechanical integrity. PloS one · 28 Sept 2026 PMID 42804447
- Exploring the Pyrimidine Scaffold for the Development of SARS-CoV-2 Mpro Inhibitors. ACS infectious diseases · 11 Sept 2026 PMID 42725964
- Redefining Fluoroquinolone Antibiotics: Design and Synthesis of Degradable Fluoroquinolones to Reduce Environmental Persistence. ChemSusChem · 31 Aug 2026 PMID 42672120
- Discovery and Optimization of Novel Nonhydroxamate LpxC Inhibitors for the Treatment of Multidrug-Resistant Gram-Negative Infections. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593942
- Development of 2,8-diazaspiro[4.5]decan-3-ones as novel sigma-1 receptor antagonists and evaluation of antihyperalgesic effects. Bioorganic chemistry · 14 Jul 2026 PMID 42447745
- Eugenol-derived carbamates as sub-nanomolar dual cholinesterase inhibitors with neuroprotective activity against Alzheimer's disease: Structure-activity relationships and molecular dynamics insights. Bioorganic chemistry · 13 Jul 2026 PMID 42442298
- Design and synthesis of novel baicalein-isoxazoles based scaffolds and their anti-microbial potential: in vitro and in silico evaluation. Bioorganic chemistry · 30 Jun 2026 PMID 42379013
- Design, synthesis, and antidiabetic evaluation of Hantzsch's 1,4-dihydropyridine-pyrazole scaffolds as stimulator of skeletal-muscle GLUT4 translocation. Bioorganic chemistry · 22 Jun 2026 PMID 42330847
By study type
Preclinical: animal, cell and lab studies (11)
- Polymeric Hydrogel-Based Multicomponent Inks Incorporated with Lanthanide-Doped Nanoconjugates for Extrusion 3D Printing. Biomacromolecules · 9 Nov 2026 PMID 43002061
- Divide and Conquer Strategy Using Piezoelectric Nanofiber Scaffolds for Stage-Specific Delivery of Bone-Targeted Exosome Mimetics with Ago/AntagomiR-126. ACS nano · 3 Nov 2026 PMID 42975284
- Granular hydrogel bioink for macroporous pancreatic spheroid scaffolds. Biofabrication · 19 Oct 2026 PMID 42896566
- Development of mechanically optimized biomimetic hybrid scaffold-stem cell constructs for functional tendon regeneration and restoration of mechanical integrity. PloS one · 28 Sept 2026 PMID 42804447
- Exploring the Pyrimidine Scaffold for the Development of SARS-CoV-2 Mpro Inhibitors. ACS infectious diseases · 11 Sept 2026 PMID 42725964
- Redefining Fluoroquinolone Antibiotics: Design and Synthesis of Degradable Fluoroquinolones to Reduce Environmental Persistence. ChemSusChem · 31 Aug 2026 PMID 42672120
- Discovery and Optimization of Novel Nonhydroxamate LpxC Inhibitors for the Treatment of Multidrug-Resistant Gram-Negative Infections. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593942
- Development of 2,8-diazaspiro[4.5]decan-3-ones as novel sigma-1 receptor antagonists and evaluation of antihyperalgesic effects. Bioorganic chemistry · 14 Jul 2026 PMID 42447745
- Eugenol-derived carbamates as sub-nanomolar dual cholinesterase inhibitors with neuroprotective activity against Alzheimer's disease: Structure-activity relationships and molecular dynamics insights. Bioorganic chemistry · 13 Jul 2026 PMID 42442298
- Design and synthesis of novel baicalein-isoxazoles based scaffolds and their anti-microbial potential: in vitro and in silico evaluation. Bioorganic chemistry · 30 Jun 2026 PMID 42379013
- Design, synthesis, and antidiabetic evaluation of Hantzsch's 1,4-dihydropyridine-pyrazole scaffolds as stimulator of skeletal-muscle GLUT4 translocation. Bioorganic chemistry · 22 Jun 2026 PMID 42330847
Written from 11 PubMed abstracts, each one listed by PMID above. Published: 2026-11-05. Drafted by language models from published abstracts; not medical advice.